Keyphrases
B Cells
100%
B Cell Immunodeficiency
75%
Clinical Aspects
75%
Thymic Malignancy
75%
Immune Complications
75%
Paraneoplastic
75%
Immunosuppression
75%
Decision Support Tool
75%
Thymoma
75%
Lactams
75%
Miscommunication
75%
Therapy-related
75%
Allergist
75%
Inpatient Consultation
75%
Standardized Tool
75%
Stem Cells
75%
Schimke Immuno-osseous Dysplasia
75%
Communication Tools
75%
Allergy
75%
Kidney Transplantation
75%
Antibiotic Allergy
75%
Paraneoplastic Syndrome
75%
Thymic Epithelial Tumors
60%
Pediatric Residents
50%
Thymic Carcinoma
45%
Antibiotics
32%
Risk Situations
32%
Inborn Errors of Immunity
30%
Recommendation Tools
24%
Sequential Transplant
24%
Haploidentical Hematopoietic Stem Cell
24%
CD19
24%
T-cell Immunodeficiency
24%
Hematopoietic chimerism
24%
Overall Satisfaction
24%
Kidney
24%
Normal Renal Function
24%
Children's Hospital
24%
Plan-Do-Study-Act Cycle
24%
T-cell Tolerance
24%
Medium Size
24%
Patient Care
24%
Needs Assessment
24%
Patient Error
24%
Pretransplant
24%
Allograft Survival
24%
Allograft Loss
24%
Immune Rejection
24%
Acute Rejection
24%
Element Components
24%
Medicine and Dentistry
Immunity
100%
Diseases
75%
Kidney Transplantation
75%
Immunosuppressive Treatment
75%
Cancer
75%
Dysplasia
75%
Immunoglobulin
75%
Stem Cell
75%
Pediatrics
75%
Lactam
75%
Thymus Cancer
75%
Epithelioma
60%
Antibiotics
50%
T Cell
50%
Thymic Carcinoma
45%
Patient Care
37%
Consultation
37%
Needs Assessment
37%
Child Care
37%
Transplantation
24%
B Cell
24%
Immune Deficiency
24%
Renal Failure
24%
Allograft
24%
Chronic Graft Rejection
24%
Kidney Function
24%
Ex Vivo
24%
Chimera
24%
Graft Survival
24%
T-Cell Tolerance
24%
Student T Test
24%
Quality Improvement
24%
Hematopoietic Cell
24%
Biological Marker
15%
Immune Checkpoint Inhibitor
15%
Patient Selection
15%
Immunological Tolerance
15%
Clinical Management
15%
Thymus
15%
Immune-Related Adverse Events
15%
Patient Monitoring
15%
Immunology and Microbiology
Immunodeficiency
100%
B Cell
100%
Immunity
100%
Stem Cell
75%
Intravenous Immunoglobulin
75%
Immunosuppression
75%
Kidney Transplantation
75%
T Cell
50%
Allograft
50%
Immunology
27%
Kidney Function
24%
T-Cell Tolerance
24%
Chimera
24%
CD19
24%
Primary Immunodeficiency
24%
Chronic Graft Rejection
24%
Hematopoietic Cell
24%
MHC Class II
15%
Immune Tolerance
15%
Thymus
15%